dc.contributor.author |
Weiss N. |
dc.contributor.author |
Tadmouri A. |
dc.contributor.author |
Mikati M. |
dc.contributor.author |
Ronjat M. |
dc.contributor.author |
De Waard M. |
dc.contributor.editor |
|
dc.date |
2007 |
dc.date.accessioned |
2017-10-05T16:01:28Z |
dc.date.available |
2017-10-05T16:01:28Z |
dc.date.issued |
2007 |
dc.identifier |
10.1007/s00424-006-0184-0 |
dc.identifier.isbn |
|
dc.identifier.issn |
00316768 |
dc.identifier.uri |
http://hdl.handle.net/10938/19537 |
dc.description.abstract |
Direct regulation of N-type calcium channels by G-proteins is essential to control neuronal excitability and neurotransmitter release. Binding of the Gβγ dimer directly onto the channel is characterized by a marked current inhibition (ON effect), whereas the pore opening- and time-dependent dissociation of this complex from the channel produce a characteristic set of biophysical modifications (OFF effects). Although G-protein dissociation is linked to channel opening, the contribution of channel inactivation to G-protein regulation has been poorly studied. Here, the role of channel inactivation was assessed by examining time-dependent G-protein de-inhibition of Cav2.2 channels in the presence of various inactivation-altering β subunit constructs. G-protein activation was produced via μ-opioid receptor activation using the DAMGO agonist. Whereas the ON effect of G-protein regulation is independent of the type of β subunit, the OFF effects were critically affected by channel inactivation. Channel inactivation acts as a synergistic factor to channel activation for the speed of G-protein dissociation. However, fast inactivating channels also reduce the temporal window of opportunity for G-protein dissociation, resulting in a reduced extent of current recovery, whereas slow inactivating channels undergo a far more complete recovery from inhibition. Taken together, these results provide novel insights on the role of channel inactivation in N-type channel regulation by G-proteins and contribute to the understanding of the physiological consequence of channel inactivation in the modulation of synaptic activity by G-protein coupled receptors. © 2006 Springer-Verlag. |
dc.format.extent |
|
dc.format.extent |
Pages: (115-129) |
dc.language |
English |
dc.publisher |
NEW YORK |
dc.relation.ispartof |
Publication Name: Pflugers Archiv European Journal of Physiology; Publication Year: 2007; Volume: 454; no. 1; Pages: (115-129); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
GENBANK: D14157, L02315, M80545, M88751, X61394 |
dc.title |
Importance of voltage-dependent inactivation in N-type calcium channel regulation by G-proteins |
dc.type |
Article |
dc.contributor.affiliation |
Weiss, N., Laboratoire Canaux Calciques, Fonctions et Pathologies, Inserm U607, CEA, 17 rue des Martyrs, 38054 Grenoble Cedex 09, France, Commissariat à l'Energie Atomique, Grenoble, France, Université Joseph Fourier, Grenoble, France |
dc.contributor.affiliation |
Tadmouri, A., Laboratoire Canaux Calciques, Fonctions et Pathologies, Inserm U607, CEA, 17 rue des Martyrs, 38054 Grenoble Cedex 09, France, Commissariat à l'Energie Atomique, Grenoble, France, Université Joseph Fourier, Grenoble, France |
dc.contributor.affiliation |
Mikati, M., Department of Pediatrics, American University, Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Ronjat, M., Laboratoire Canaux Calciques, Fonctions et Pathologies, Inserm U607, CEA, 17 rue des Martyrs, 38054 Grenoble Cedex 09, France, Commissariat à l'Energie Atomique, Grenoble, France, Université Joseph Fourier, Grenoble, France |
dc.contributor.affiliation |
De Waard, M., Laboratoire Canaux Calciques, Fonctions et Pathologies, Inserm U607, CEA, 17 rue des Martyrs, 38054 Grenoble Cedex 09, France, Commissariat à l'Energie Atomique, Grenoble, France, Université Joseph Fourier, Grenoble, France |
dc.contributor.authorAddress |
De Waard, M.; Laboratoire Canaux Calciques, Fonctions et Pathologies, Inserm U607, CEA, 17 rue des Martyrs, 38054 Grenoble Cedex 09, France; email: michel.de-waard@cea.fr |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Pediatrics and Adolescent Medicine; |
dc.contributor.authorDepartment |
Pediatrics and Adolescent Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
michel.de-waard@cea.fr |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Weiss, N |
dc.contributor.authorInitials |
Tadmouri, A |
dc.contributor.authorInitials |
Mikati, M |
dc.contributor.authorInitials |
Ronjat, M |
dc.contributor.authorInitials |
De Waard, M |
dc.contributor.authorOrcidID |
De Waard, Michel-0000-0002-2782-9615 |
dc.contributor.authorReprintAddress |
De Waard, M (reprint author), CEA, U607, INSERM, Lab Canaux Calciques Fonct and Pathol, 17 Rue Martyrs, F-38054 Grenoble, France. |
dc.contributor.authorResearcherID |
Weiss, Norbert-G-5330-2014; De Waard, Michel-G-7406-2014 |
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Agler HL, 2005, NEURON, V46, P891, DOI 10.1016-j.neuron.2005.05.011; Ahern CA, 2003, BIOPHYS J, V84, P942; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038-367072a0; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038-340153a0; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016-S0896-6273(03)00801-8; Bertram R, 2003, J NEUROPHYSIOL, V90, P1643, DOI 10.1152-jn.00190.2003; BOLAND LM, 1993, J NEUROSCI, V13, P516; Brody DL, 1997, J PHYSIOL-LONDON, V499, P637; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016-S0092-8674(00)81877-2; Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066; Canti C, 2000, J PHYSIOL-LONDON, V527, P419, DOI 10.1111-j.1469-7793.2000.t01-1-00419.x; Canti C, 1999, J NEUROSCI, V19, P6855; Chien AJ, 1996, J BIOL CHEM, V271, P26465; De W.M., 1997, NATURE, V385, P446; De Waard M, 2005, TRENDS PHARMACOL SCI, V26, P427, DOI 10.1016-j.tips.2005.06.008; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016-0896-6273(94)90363-8; DOUPNIK CA, 1994, J MEMBRANE BIOL, V140, P47; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519; EPPIG JJ, 1976, IN VITRO CELL DEV B, V12, P418; Feng ZP, 2001, J BIOL CHEM, V276, P45051, DOI 10.1074-jbc.M107784200; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074-jbc.M106231200; Herlitze S, 2003, J BIOENERG BIOMEMBR, V35, P621, DOI 10.1023-B:JOBB.0000008027.19384.c0; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073-pnas.94.4.1512; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038-380258a0; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016-0166-2236(94)90157-0; IKEDA SR, 1996, NATURE, V380, P258; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016-S0896-6273(01)80054-4; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038-340639a0; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007-BF00586670; Meir A, 2002, PFLUG ARCH EUR J PHY, V444, P263, DOI 10.1007-s00424-002-0803-3; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016-0896-6273(94)90428-6; Page KM, 1998, J NEUROSCI, V18, P4815; Page KM, 1997, J NEUROSCI, V17, P1330; Patil PG, 1996, BIOPHYS J, V71, P2509; PENINGTON NJ, 1991, J NEUROSCI, V11, P3594; Qin N, 1996, AM J PHYSIOL-CELL PH, V271, pC1539; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073-pnas.94.16.8866; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016-j.tins.2003.10.003; Restituito S, 2000, J NEUROSCI, V20, P9046; Sandoz G, 2004, EUR J NEUROSCI, V19, P1759, DOI 10.1111-j.1460.9568.2004.03216.x; SCOTT RH, 1990, BRIT J PHARMACOL, V99, P629; Scott VES, 1996, J BIOL CHEM, V271, P3207; Simen AA, 2001, J NEUROSCI, V21, P7587; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111-j.1469-7793.2000.t01-1-00377.x; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074-jbc.M000399200; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038-366156a0; Weiss N, 2006, NEUROSCI RES, V56, P332, DOI 10.1016-j.neures.2006.08.002; Weiss N, 2007, J NEUROSCI METH, V160, P26, DOI 10.1016-j.jneumeth.2006.08.010; Williams S, 1997, J NEUROSCI, V17, P1625; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016-S0166-2236(96)01015-6; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385-CBB:34:1:79; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038-385442a0; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016-S0896-6273(00)80229-9 |
dc.description.citedCount |
8 |
dc.description.citedTotWOSCount |
9 |
dc.description.citedWOSCount |
9 |
dc.format.extentCount |
15 |
dc.identifier.articleNo |
|
dc.identifier.coden |
PFLAB |
dc.identifier.pubmedID |
17171365 |
dc.identifier.scopusID |
33847661607 |
dc.identifier.url |
|
dc.publisher.address |
233 SPRING ST, NEW YORK, NY 10013 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Pflugers Arch. |
dc.relation.ispartOfIssue |
1 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Pflugers Archiv European Journal of Physiology |
dc.relation.ispartofPubTitleAbbr |
Pflug. Arch. Eur. J. Physiol. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
454 |
dc.source.ID |
WOS:000244692900011 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
β subunit |
dc.subject.otherAuthKeyword |
μ-opioid receptor |
dc.subject.otherAuthKeyword |
Cav2.2 subunit |
dc.subject.otherAuthKeyword |
G-protein |
dc.subject.otherAuthKeyword |
G-protein coupled receptor |
dc.subject.otherAuthKeyword |
Inactivation |
dc.subject.otherAuthKeyword |
N-type calcium channel |
dc.subject.otherChemCAS |
enkephalin[2 dextro alanine 4 methylphenylalanine 5 glycine], 78123-71-4 |
dc.subject.otherChemCAS |
Calcium Channels, N-Type |
dc.subject.otherChemCAS |
GTP-Binding Proteins, EC 3.6.1.- |
dc.subject.otherChemCAS |
Protein Isoforms |
dc.subject.otherChemCAS |
Receptors, Opioid, mu |
dc.subject.otherIndex |
calcium channel N type |
dc.subject.otherIndex |
enkephalin[2 dextro alanine 4 methylphenylalanine 5 glycine] |
dc.subject.otherIndex |
G protein coupled receptor |
dc.subject.otherIndex |
guanine nucleotide binding protein |
dc.subject.otherIndex |
mu opiate receptor |
dc.subject.otherIndex |
animal cell |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
beta chain |
dc.subject.otherIndex |
controlled study |
dc.subject.otherIndex |
dissociation |
dc.subject.otherIndex |
inhibition kinetics |
dc.subject.otherIndex |
nonhuman |
dc.subject.otherIndex |
nucleotide sequence |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
regulatory mechanism |
dc.subject.otherIndex |
Animals |
dc.subject.otherIndex |
Calcium Channels, N-Type |
dc.subject.otherIndex |
Electric Conductivity |
dc.subject.otherIndex |
Electrophysiology |
dc.subject.otherIndex |
GTP-Binding Proteins |
dc.subject.otherIndex |
Kinetics |
dc.subject.otherIndex |
Protein Isoforms |
dc.subject.otherIndex |
Rabbits |
dc.subject.otherIndex |
Rats |
dc.subject.otherIndex |
Receptors, Opioid, mu |
dc.subject.otherIndex |
Time Factors |
dc.subject.otherKeywordPlus |
G-BETA-GAMMA |
dc.subject.otherKeywordPlus |
I-II-LOOP |
dc.subject.otherKeywordPlus |
CA2+ CHANNEL |
dc.subject.otherKeywordPlus |
SYMPATHETIC NEURONS |
dc.subject.otherKeywordPlus |
COUPLED RECEPTORS |
dc.subject.otherKeywordPlus |
AMINO-TERMINUS |
dc.subject.otherKeywordPlus |
NEUROTRANSMITTER RELEASE |
dc.subject.otherKeywordPlus |
SYNAPTIC-TRANSMISSION |
dc.subject.otherKeywordPlus |
INTRACELLULAR LOOP |
dc.subject.otherKeywordPlus |
ALPHA(1) SUBUNIT |
dc.subject.otherWOS |
Physiology |